Benzinga | Nov 5, 2020 04:04AM EST

SVB Leerink Maintains Outperform on Macrogenics, Lowers Price Target to $37

SVB Leerink maintains Macrogenics (NASDAQ:MGNX) with a Outperform and lowers the price target from $38 to $37.